Desacetylcinobufagin

CAS No. 4026-95-3

Desacetylcinobufagin ( Deacetylcinobufagin )

Catalog No. M21666 CAS No. 4026-95-3

Deacetylcinobufagin a natural product shows potent activities against Hela and A375 cells in vitro.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 115 Get Quote
10MG 171 Get Quote
25MG 286 Get Quote
50MG 422 Get Quote
100MG 620 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Desacetylcinobufagin
  • Note
    Research use only not for human use.
  • Brief Description
    Deacetylcinobufagin a natural product shows potent activities against Hela and A375 cells in vitro.
  • Description
    Deacetylcinobufagin a natural product shows potent activities against Hela and A375 cells in vitro.
  • Synonyms
    Deacetylcinobufagin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4026-95-3
  • Formula Weight
    400.51
  • Molecular Formula
    C24H30O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥25 mg/mL (62.42 mM)
  • SMILES
    C[C@]([C@@H](C(C=C1)=COC1=O)[C@]2O)(CC[C@@]3([H])[C@@]4([H])CC[C@@]5([H])[C@@]3(CC[C@](O)C5)C)[C@@]64[C@@H]2O6
  • Chemical Name
    3-beta16-beta-Dihydroxy-1415-beta-epoxy-5-beta-bufa-2022-dienolide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Xiao-Chi Ma et al. Efficient Isolation and Purification of Five Products From Microbial Biotransformation of Cinobufagin by High-Speed Counter-Current Chromatography. J Sep Sci 33 (15) 2272-7
molnova catalog
related products
  • Jujuboside B

    Jujuboside B has potent inhibitory effects on collagen-, thrombin-, AA-, and ADP-induced aggregation, and also exhibits superior protection on the thromboembolic model.

  • 7-Acetyllycopsamine

    Lycopsamine `1-acetate is a bioactive chemical.

  • AD 01

    FKBPL (FK506-binding protein like)-based peptide. Binds to and upregulates expression of CD44. Inhibits breast cancer stem cell (BCSC) growth. Decreases pluripotency markers and promotes differentiation of BCSCs. Also inhibits endothelial cell migration as well as tubule and microvessel formation in vitro and in vivo. Blocks tumor growth in xenograft models.